Blog Posts | BrainReader

Brainreader Insights

From Subjective to Objective: How Volumetric MRI Changes Brain Imaging

Radiologists and neurologists have long relied on MRI as the gold standard for evaluating brain structure. Yet, conventional interpretation often depends heavily on the reader’s expertise and visual j...

Jan 27, 2026

Brainreader Appoints Cyrus A. Raji, MD, PhD as Chief Medical Officer

Brainreader appointed Cyrus A. Raji, MD, PhD, as consulting Chief Medical Officer, adding internationally recognized expertise in quantitative MRI and neurodegeneration to accelerate clinical adoption and innovation in brain volumetric imaging.

Jan 14, 2026

Brainreader Appoints Steve Green as Head of U.S. Sales

Brainreader has appointed Steve Green as Head of U.S. Sales to lead commercial strategy and expand adoption of its AI-driven brain volumetric solutions in the U.S.

Dec 22, 2025

What Is Quantitative MRI (qMRI) and Why Does It Matter?

Magnetic resonance imaging (MRI) has long been a cornerstone of brain imaging, but conventional scans are largely interpreted visually. While valuable, this approach can sometimes miss subtle structur...

Oct 30, 2025

Brainreader Secures $7.3M to Drive Global Expansion of AI-Powered Brain Diagnostics

Danish medtech company Brainreader A/S has successfully completed a financing round of USD 7.3 million (EUR 6.6 million) to accelerate the global rollout of its AI-driven diagnostic platform Neuroread...

May 31, 2025

AI-Enabled MRI Volumetry Accurately Differentiates Between Neurocognitive Disorders

Los Angeles, California — September 11, 2024 A peer-reviewed study published in BMC Neurology demonstrates the power of AI-enabled MRI volumetry in distinguishing between common neurocognitive disorde...

Sep 11, 2024

New Study Highlights Diagnostic Power of Neuroreader in Alzheimer’s

A BMC Neurology study shows that MRI volumetry can accurately distinguish major neurocognitive disorders by identifying distinct patterns of brain volume loss using Neuroreader.

Sep 11, 2024

PNI Study Links Muscular Strength and Mobility to Brain Health in Alzheimer’s Disease

A new clinical study from the Pacific Neuroscience Institute (PNI) has identified a significant relationship between muscular strength, mobility, and brain volume in individuals with Alzheimer’s disea...

Jan 1, 2023

Brainreader Partners with Phenome Health on Landmark Million-Person Brain Health Trial

Brainreader Inc. announced it is in advanced negotiations to provide its Neuroreader® software as the exclusive volumetric brain analytics platform for Phenome Health’s Beyond the Human Genome Project.

Nov 29, 2022

Brainreader Welcomes Dr. Basant Kumar Bajpai as QA/RA Manager

Dr. Basant Bajpai, PhD. has recently joined Brainreader as our QA/RA Manager. Dr. Bajpai earned a doctorate in Neuroscience (Brain Monitoring) at Kaunas University of Technology with specialty in Trau...

Jul 15, 2022

Brainreader and INFINITT North America Announce Strategic Partnership

INFINITT North America and Brainreader Inc. announced a strategic partnership to expand adoption of Brainreader’s FDA-cleared Neuroreader® software, which analyzes MRI scans to quickly visualize and quantify brain structures, identifying abnormalities in under ten minutes.

Jun 9, 2022

Precision Medicine Approach to Alzheimer’s Disease Shows Cognitive and MRI Improvements in Pilot Study

Burlingame, Calif. | July 6, 2022 News provided by Apollo Health Over 80% of Patients Show Cognitive Improvement Using a Precision Medicine Protocol Amid repeated failures of traditional drug trials f...

Jun 7, 2022

Request a Sample Neuroreader® Report

See how automated brain volumetrics can enhance diagnostic confidence and streamline MRI interpretation.

Customer Name *

Job Title *

Email Address *

(Please use your professional email)

Organization Name *

Organization Type *

Primary Area of Interest

MRI Volume

Comments

Message Subject *

Request Your Free Sample Report

Request a Sample Neuroreader® Report

Follow us here

Contact us

Customer login: